- Home
- MBI vs MNPR Comparison
MBI vs MNPR Comparison
Compare MBI & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- MNPR
- Stock Information
- Founded
- MBI 1973
- MNPR 2014
- Country
- MBI United States
- MNPR United States
- Employees
- MBI N/A
- MNPR N/A
- Industry
- MBI Property-Casualty Insurers
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- MBI Finance
- MNPR Health Care
- Exchange
- MBI Nasdaq
- MNPR Nasdaq
- Market Cap
- MBI 231.2M
- MNPR 249.5M
- IPO Year
- MBI 1987
- MNPR 2019
- Fundamental
- Price
- MBI $4.31
- MNPR $39.42
- Analyst Decision
- MBI Buy
- MNPR Strong Buy
- Analyst Count
- MBI 2
- MNPR 5
- Target Price
- MBI $6.25
- MNPR $59.50
- AVG Volume (30 Days)
- MBI 283.5K
- MNPR 17.8K
- Earning Date
- MBI 05-08-2025
- MNPR 05-20-2025
- Dividend Yield
- MBI N/A
- MNPR N/A
- EPS Growth
- MBI N/A
- MNPR N/A
- EPS
- MBI N/A
- MNPR N/A
- Revenue
- MBI $28,000,000.00
- MNPR N/A
- Revenue This Year
- MBI N/A
- MNPR N/A
- Revenue Next Year
- MBI N/A
- MNPR N/A
- P/E Ratio
- MBI N/A
- MNPR N/A
- Revenue Growth
- MBI 1300.00
- MNPR N/A
- 52 Week Low
- MBI $3.22
- MNPR $1.72
- 52 Week High
- MBI $7.46
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- MBI 41.43
- MNPR 49.46
- Support Level
- MBI $4.60
- MNPR $37.81
- Resistance Level
- MBI $4.97
- MNPR $44.40
- Average True Range (ATR)
- MBI 0.24
- MNPR 3.61
- MACD
- MBI 0.04
- MNPR -0.38
- Stochastic Oscillator
- MBI 22.67
- MNPR 18.32
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.